COMMUNIQUÉS West-GlobeNewswire

Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple Negative Breast Cancer in Collaboration with Roswell Park Comprehensive Cancer Center
08/01/2019
The Phase II Study Will Combine Hemispherx’s Ampligen with Keytruda OCALA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth [...]
Phoenix Life Sciences International Announces 2019 International Expansion Strategy
08/01/2019
DENVER, CO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, or the “Company”), an international adaptive healthcare solutions company, today [...]
Genmab Achieves USD 75 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
08/01/2019
Company Announcement Genmab to receive milestone payment of USD 75 million in DARZALEX collaboration Milestone triggered by sales of DARZALEX reaching USD 2 billion in a calendar year Copenhagen, Denmark; January 8, [...]
Director/PDMR Shareholding
08/01/2019
Director/PDMR Shareholding January 8, 2019 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging [...]
Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2018
08/01/2019
LYON, France, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Décembre 2018
08/01/2019
LYON, France, 08 janv. 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment B - Code ISIN : [...]
2019 FINANCIAL COMMUNICATION CALENDAR
08/01/2019
2019 FINANCIAL COMMUNICATION CALENDAR Paris, January 8, 2019 – 5.45 pm Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), leading French group in the field of specialty in vitro medical diagnostics, announces [...]
CALENDRIER DE COMMUNICATION FINANCIERE 2019
08/01/2019
CALENDRIER DE COMMUNICATION FINANCIERE 2019 Paris, le 8 janvier 2019 – 17h45 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, présente [...]
Ornish Lifestyle Medicine by Sharecare named best heart-healthy diet for 2019 by U.S. News
08/01/2019
ATLANTA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Sharecare, the digital health company that helps people manage all their health in one place, today announced its Ornish Lifestyle Medicine™ program has been recognized for [...]
Q-Centrix Report Shows Value-Based Care and Quality Program Participation on the Rise, Exposes Shortages of Resources Critical for Meeting Quality Goals
08/01/2019
Analysis estimates steady growth in registry participation while reporting to such programs is becoming increasingly complex, highlights the emergence of state-level programs. Chicago, Jan. 08, 2019 (GLOBE NEWSWIRE) -- [...]
Dermatology Hall of Fame to Recognize Industry Pioneers
08/01/2019
Inaugural event will be held next month in Washington DC NORWALK, Conn., Jan. 08, 2019 (GLOBE NEWSWIRE) -- The Dermatology Hall of Fame will honor its first inductees February 28, 2019, in Washington, D.C. The [...]
UPDATE: Westleaf Inc. Going Public Wednesday, January 9th -- CFN Media
08/01/2019
Seattle, WA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
OnePoint Patient Care Opens Hospice-Dedicated Pharmacy in Orlando
08/01/2019
Second Florida-based pharmacy provides expert local dispensing for Central Region MORTON GROVE, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- OnePoint Patient Care, the market leader in local hospice pharmacy and e- [...]
ERC-USA Initiates Therapy Under Right to Try Law With First Patient In California Using Investigational Compound ERC1671 for Treatment of Glioblastoma
08/01/2019
IRVINE, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine have initiated treatment with the company’s investigational compound ERC1671, also known in Europe as Gliovac, which is [...]
Diamond CBD Enters $21 Billion Vending Machine Market With Innovative Hemp-Derived CBD Product Showcase at CES 2019
08/01/2019
Booth Co-Hosted with interactive vending machine partner CloudPay Technologies to be the only CBD brand available at world's most influential consumer electronics event MIAMI, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via OTC [...]
Westleaf Inc. Going Public Wednesday, January 9th -- CFN Media
08/01/2019
Seattle, WA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure
08/01/2019
MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that the Centers for [...]
Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children
08/01/2019
PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Cognoa , a digital behavioral health company, announced today that Cambia Health Solutions, Inc . (Cambia) is incorporating Cognoa’s evidence-based platform within [...]
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for ALS
08/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, [...]

Pages